HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Rocha, A. S. Articles by Soares, P. Search for Related Content PubMed PubMed Citation Articles by Rocha, A. S. Articles by Soares, P.

¹ IPATIMUP, Institute of Molecular Pathology and Immunology of the University of Porto, Rua Roberto Frias s/n, 4200-065 Porto, Portugal
² Department of Pathology, Hospital São João, Porto, Portugal
³ Department of Pathology, Medical Faculty, University of São Paulo, São Paulo, Brazil
⁴ Department of Pathology, Medical Faculty, University of Porto, Porto, Portugal

(Requests for offprints should be addressed to A S Rocha; Email: arocha{at}ipatimup.pt)

Thyroid cancer constitutes the most frequent endocrine neoplasia. Targeted expression of rearranged during transfection (RET)/papillary thyroid carcinoma (PTC) and V600E V-raf murine sarcoma viral oncogene homolog B1 (BRAF) to the thyroid glands of transgenic mice results in tumours similar to those of human PTC, providing evidence for the involvement of these oncogenes in PTC. Kato et al. developed a mouse model that mimics the full spectrum of the human follicular form of thyroid cancer (FTC). FTC rapidly develops in these mice through introduction of the thyroid hormone receptor ß (THRB)^PV mutant on the background of the inactivated THRB wt locus. Our aim was to verify if, in the context of human follicular thyroid carcinogenesis, THRB acted as a tumour suppressor gene. We screened for mutations of the THRB gene in the hot-spot region, spanning exons 7–10, in 51 thyroid tumours and six thyroid cancer cell lines by PCR and direct sequencing. We did not find mutations in any of the tumours or cell lines analysed. Our findings suggest that, in contrast to the findings on the THRB-mutant transgenic mice, THRB gene mutations are not a relevant mechanism for human thyroid carcinogenesis.

This article has been cited by other articles:

				C.-H. Liao, S.-C. Yeh, Y.-H. Huang, R.-N. Chen, M.-M. Tsai, W.-J. Chen, H.-C. Chi, P.-J. Tai, C.-J. Liao, S.-M. Wu, et al. Positive regulation of spondin 2 by thyroid hormone is associated with cell migration and invasion Endocr. Relat. Cancer, January 29, 2010; 17(1): 99 - 111. [Abstract] [Full Text] [PDF]

				B. Joseph, M. Ji, D. Liu, P. Hou, and M. Xing Lack of Mutations in the Thyroid Hormone Receptor (TR) {alpha} and Genes but Frequent Hypermethylation of the TR Gene in Differentiated Thyroid Tumors J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4766 - 4770. [Abstract] [Full Text] [PDF]